Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep;12(18):2517-2520.
doi: 10.1111/1759-7714.14107. Epub 2021 Aug 10.

Low-grade fibromyxoid sarcoma arising from the lung: A case report

Affiliations
Case Reports

Low-grade fibromyxoid sarcoma arising from the lung: A case report

Ryuichi Yoshimura et al. Thorac Cancer. 2021 Sep.

Abstract

Low-grade fibromyxoid sarcoma (LGFMS) is a rare sarcoma subtype that most commonly arises in young adults. This tumor typically presents in the deep soft tissues of the proximal extremities or trunk as a painless mass. Although the most common site of LGFMS metastasis is the lung, it is rarely the primary site. Here, we report a case of primary pulmonary LGFMS. A 22-year-old asymptomatic man was referred to our hospital for investigation of a lung mass that had been discovered incidentally. Computed tomography (CT) showed a well-defined mass 4.0 cm in diameter in the upper lobe of the right lung. Malignancy was suggested by focal uptake of 18F-fluorodeoxyglucose positron-emission tomography (18-FDG-PET). Following surgery, postoperative histological analysis of the resected specimen demonstrated LGFMS based on histological and immunohistological findings. In particular, mucin 4 showed diffuse positivity in the spindle-shaped tumor cells. In conclusion, LGFMS can arise in the lungs, and physicians should consider this entity as a differential diagnosis for solitary lung mass in young adults.

Keywords: Evans tumor; low-grade fibromyxoid sarcoma; lung tumor.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Chest X‐ray findings. (a) No shadows had been detected on simple chest X‐ray 1.5 years previously. (b) Chest X‐ray indicated a smooth, mass shadow in the right upper lung
FIGURE 2
FIGURE 2
Preoperative imaging. (a) Computed tomography (CT) indicated a solid mass with peripheral atelectasis in the right upper lobe. (b) 18‐fluorodeoxyglucose (18‐FDG)‐positron emission tomography (PET) showed focal FDG uptake, with a maximum standardized uptake value of 5.59 in the mass
FIGURE 3
FIGURE 3
(a) Divided surface of the tumor showed a tan‐whitish, homogeneous, solid tumor. (b) Histological examination showed spindle‐shaped cells in a myxoid and fibrous matrix. (c) The rosettes were composed of a core of mature collagen surrounded by epithelioid cell. (d) Diffuse MUC4 positivity was seen in the tumor cells

Similar articles

Cited by

References

    1. Evans HL. Low‐grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987;88:615–9. - PubMed
    1. Chamberlain F, Engelmann B, Al‐Muderis O, et al. Low‐grade fibromyxoid sarcoma: treatment outcomes and efficacy of chemotherapy. In Vivo. 2020;34:239–45. - PMC - PubMed
    1. Kim L, Yoon YH, Choi SJ, Han JY, Park IS, Kim JM, et al. Hyalinizing spindle cell tumor with giant rosettes arising in the lung: report of a case with FUS‐CREB3L2 fusion transcripts. Pathol Int. 2007;57:153–7. - PubMed
    1. Magro G, Fraggetta F, Manusia M, Mingrino A. Hyalinizing spindle cell tumor with giant rosettes: a previously undescribed lesion of the lung. Am J Surg Pathol. 1998;22:1431–3. - PubMed
    1. Maretty‐Nielsen K, Baerentzen S, Keller J, Dyrop HB, Safwat A. Low‐grade fibromyxoid sarcoma: incidence, treatment strategy of metastases, and clinical significance of the FUS gene. Sarcoma. 2013;2013:256280. 10.1155/2013/256280 - DOI - PMC - PubMed

Publication types